Cargando…
Dysglycemia in young women attenuates the protective effect against fatty liver disease
INTRODUCTION: Sexual dimorphism has been reported in non-alcoholic fatty liver disease (NAFLD), similar to the sex differences evident with cardiovascular disease. Type 2 diabetes mellitus (T2D) significantly increases the risk and severity of NAFLD, but there is scarce information on whether T2D or...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720265/ https://www.ncbi.nlm.nih.gov/pubmed/36479218 http://dx.doi.org/10.3389/fendo.2022.971864 |
_version_ | 1784843518250844160 |
---|---|
author | Pérez-Montes de Oca, Alejandra Julián, María Teresa Pera, Guillem Caballería, Llorenç Morillas, Rosa Torán, Pere Expósito, Carmen Franch-Nadal, Josep Mauricio, Didac Alonso, Nuria |
author_facet | Pérez-Montes de Oca, Alejandra Julián, María Teresa Pera, Guillem Caballería, Llorenç Morillas, Rosa Torán, Pere Expósito, Carmen Franch-Nadal, Josep Mauricio, Didac Alonso, Nuria |
author_sort | Pérez-Montes de Oca, Alejandra |
collection | PubMed |
description | INTRODUCTION: Sexual dimorphism has been reported in non-alcoholic fatty liver disease (NAFLD), similar to the sex differences evident with cardiovascular disease. Type 2 diabetes mellitus (T2D) significantly increases the risk and severity of NAFLD, but there is scarce information on whether T2D or altered glucose metabolism can modify the prevalence of NAFLD in men and women of reproductive age. PURPOSE: To investigate the relationship between age, sex and NAFLD in subjects with and without dysglycemia. MATERIALS AND METHODS: We analyzed 2,790 patients. NAFLD was characterized using established diagnostic criteria: one or more positive results on the fatty liver index and hepatic ultrasound. Liver fibrosis (liver stiffness measurement [LSM] ≥8.0 kPa) was assessed by Fibroscan(®). For analysis purposes, we included both T2D and prediabetes under the predefined condition of dysglycemia. RESULTS: The global prevalence of NAFLD was higher in men than in women (50% and 34%; P<0.001), and the prevalence increased with age in both sexes. Older women (≥ 50 years) had a higher prevalence than younger women (<50 years), both in the overall cohort and in non-dysglycemic subjects. In dysglycemic subjects, the prevalence of NAFLD was slightly higher in men (68% vs 61%, p=0.021); in younger subjects, there were no differences in the prevalence of NAFLD between men and women (68% vs 64%, respectively; p=0.635). We found an interaction between dysglycemia and female sex (odds ratio [OR] 1.6 95% confidence interval [CI] 1.0-2.4, p=0.030), and between and age ≥50 years (OR 0.6, 95% CI 0.3-1.0, p=0.046). The global prevalence of LSM ≥8.0 kPa was higher in men compared with women (8% vs 4%; p< 0.001). This prevalence increased with age, mainly in men. We did not find any association between liver fibrosis and age and gender. CONCLUSIONS: While the global prevalence of NAFLD is higher in men than in women across all ages, younger women with dysglycemia have a similar risk of developing NAFLD as men of a similar age. Therefore, the presence of dysglycemia may erase the protective effect of female sex against fatty liver disease. |
format | Online Article Text |
id | pubmed-9720265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97202652022-12-06 Dysglycemia in young women attenuates the protective effect against fatty liver disease Pérez-Montes de Oca, Alejandra Julián, María Teresa Pera, Guillem Caballería, Llorenç Morillas, Rosa Torán, Pere Expósito, Carmen Franch-Nadal, Josep Mauricio, Didac Alonso, Nuria Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Sexual dimorphism has been reported in non-alcoholic fatty liver disease (NAFLD), similar to the sex differences evident with cardiovascular disease. Type 2 diabetes mellitus (T2D) significantly increases the risk and severity of NAFLD, but there is scarce information on whether T2D or altered glucose metabolism can modify the prevalence of NAFLD in men and women of reproductive age. PURPOSE: To investigate the relationship between age, sex and NAFLD in subjects with and without dysglycemia. MATERIALS AND METHODS: We analyzed 2,790 patients. NAFLD was characterized using established diagnostic criteria: one or more positive results on the fatty liver index and hepatic ultrasound. Liver fibrosis (liver stiffness measurement [LSM] ≥8.0 kPa) was assessed by Fibroscan(®). For analysis purposes, we included both T2D and prediabetes under the predefined condition of dysglycemia. RESULTS: The global prevalence of NAFLD was higher in men than in women (50% and 34%; P<0.001), and the prevalence increased with age in both sexes. Older women (≥ 50 years) had a higher prevalence than younger women (<50 years), both in the overall cohort and in non-dysglycemic subjects. In dysglycemic subjects, the prevalence of NAFLD was slightly higher in men (68% vs 61%, p=0.021); in younger subjects, there were no differences in the prevalence of NAFLD between men and women (68% vs 64%, respectively; p=0.635). We found an interaction between dysglycemia and female sex (odds ratio [OR] 1.6 95% confidence interval [CI] 1.0-2.4, p=0.030), and between and age ≥50 years (OR 0.6, 95% CI 0.3-1.0, p=0.046). The global prevalence of LSM ≥8.0 kPa was higher in men compared with women (8% vs 4%; p< 0.001). This prevalence increased with age, mainly in men. We did not find any association between liver fibrosis and age and gender. CONCLUSIONS: While the global prevalence of NAFLD is higher in men than in women across all ages, younger women with dysglycemia have a similar risk of developing NAFLD as men of a similar age. Therefore, the presence of dysglycemia may erase the protective effect of female sex against fatty liver disease. Frontiers Media S.A. 2022-11-21 /pmc/articles/PMC9720265/ /pubmed/36479218 http://dx.doi.org/10.3389/fendo.2022.971864 Text en Copyright © 2022 Pérez-Montes de Oca, Julián, Pera, Caballería, Morillas, Torán, Expósito, Franch-Nadal, Mauricio and Alonso https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Pérez-Montes de Oca, Alejandra Julián, María Teresa Pera, Guillem Caballería, Llorenç Morillas, Rosa Torán, Pere Expósito, Carmen Franch-Nadal, Josep Mauricio, Didac Alonso, Nuria Dysglycemia in young women attenuates the protective effect against fatty liver disease |
title | Dysglycemia in young women attenuates the protective effect against fatty liver disease |
title_full | Dysglycemia in young women attenuates the protective effect against fatty liver disease |
title_fullStr | Dysglycemia in young women attenuates the protective effect against fatty liver disease |
title_full_unstemmed | Dysglycemia in young women attenuates the protective effect against fatty liver disease |
title_short | Dysglycemia in young women attenuates the protective effect against fatty liver disease |
title_sort | dysglycemia in young women attenuates the protective effect against fatty liver disease |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720265/ https://www.ncbi.nlm.nih.gov/pubmed/36479218 http://dx.doi.org/10.3389/fendo.2022.971864 |
work_keys_str_mv | AT perezmontesdeocaalejandra dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease AT julianmariateresa dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease AT peraguillem dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease AT caballeriallorenc dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease AT morillasrosa dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease AT toranpere dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease AT expositocarmen dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease AT franchnadaljosep dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease AT mauriciodidac dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease AT alonsonuria dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease |